Fig. 2From: Prognostic significance of the pre-chemotherapy lymphocyte-to-monocyte ratio in patients with previously untreated metastatic colorectal cancer receiving FOLFOX chemotherapyKaplan–Meier estimates of progression-free and overall survival of patients with newly diagnosed metastatic colorectal cancer according to the changes in LMR before and after chemotherapy. a progression-free survival, b overall survivalBack to article page